Tissue ablation technologies for localized prostate cancer

被引:18
|
作者
Gillett, MD [1 ]
Gettman, MT [1 ]
Zincke, H [1 ]
Blute, ML [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Urol, Rochester, MN 55905 USA
关键词
D O I
10.4065/79.12.1547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Traditional treatments for men with localized, prostate cancer have Included both surgical removal and radiation therapy, with their potential adverse effects on patient quality of life. Thus, there has been Increasing interest in the development of minimmally invasive procedures that use various technologies to deliver lethal doses of heat or, cold to the prostate In an attempt to kill cancer cells. At the same time, it Is vital that these newer techniques ablate prostate tissue and spare vital periprostatic organs essential for maintaining function and quality of life. In this article, we evaluate the current status of tissue ablation modalities In the treatment of clinically localized prostate cancer, focusing on the different methods, early results, and possible future directions. Although still in the beginning stages, these newer forms of treatment offer, exciting potential for first-line and second-line treatment-of this common urologic malignancy.
引用
收藏
页码:1547 / 1555
页数:9
相关论文
共 50 条
  • [31] SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer
    Ghai, Sangeet
    JOURNAL OF UROLOGY, 2019, 202 (05): : 959 - 959
  • [32] Focal ablation therapy presents promising results for selectively localized prostate cancer patients
    Dechao Feng
    Dengxiong Li
    Yuhan Xiao
    Ruicheng Wu
    Jie Wang
    Chi Zhang
    Chinese Journal of Cancer Research, 2023, 35 (04) : 424 - 430
  • [33] Focal ablation therapy presents promising results for selectively localized prostate cancer patients
    Feng, Dechao
    Li, Dengxiong
    Xiao, Yuhan
    Wu, Ruicheng
    Wang, Jie
    Zhang, Chi
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (04) : 424 - 430
  • [34] Are We Ready for Focal Dose Radio-Ablation in the Treatment of Localized Prostate Cancer?
    Zelefsky, Michael J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (02): : 302 - 304
  • [35] ASSESSMENT OF PATIENT PERSPECTIVE ON BENEFIT AND RISK (B-R) ASSOCIATED WITH HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) FOR THE ABLATION OF PROSTATE TISSUE IN MEN WITH LOCALIZED PROSTATE CANCER
    Babalola, Olufemi
    Sonn, Geoffrey
    Siddiqui, Minhaj
    Viviano, Charles
    JOURNAL OF UROLOGY, 2021, 206 : E402 - E402
  • [36] Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
    Moschini, Marco
    Spahn, Martin
    Mattei, Agostino
    Cheville, John
    Karnes, R. Jeffrey
    BMC MEDICINE, 2016, 14
  • [37] A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
    Juracek, Jaroslav
    Madrzyk, Marie
    Stanik, Michal
    Ruckova, Michaela
    Trachtova, Karolina
    Malcikova, Hana
    Lzicarova, Eva
    Barth, Dominik A.
    Pichler, Martin
    Slaby, Ondrej
    PROSTATE, 2023, 83 (04): : 340 - 351
  • [38] Effect of androgen deprivation on epithelial and mesenchymal tissue components in localized prostate cancer
    Hellstrom, M
    Ranefall, P
    Wester, K
    Brandstedt, S
    Busch, C
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (03): : 421 - 426
  • [39] Blood and tissue nitric oxide and malondialdehyde are prognostic indicators of localized prostate cancer
    Meltem Ozlen Dillioglugil
    Haluk Mekık
    Bahar Muezzinoglu
    T. Alp Ozkan
    Cennet Gural Demir
    Ozdal Dillioglugil
    International Urology and Nephrology, 2012, 44 : 1691 - 1696
  • [40] Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer
    Ingrosso, Gianluca
    Ali, Emanuele
    Marani, Simona
    Saldi, Simonetta
    Bellavita, Rita
    Aristei, Cynthia
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):